Our magazine is free!

for living with diabetes

Articles related to "Bydureon" »

Dulaglutide — new Lilly injectable

Friday, November 30th, 2012 | 0 Comments
Eli Lilly & Co says its once-weekly injectible drug, dulaglutide, has outperformed three other widely taken drugs in three just-concluded Phase III studies. According to Lilly, dulaglutide, a GLP-1 analog, worked better to reduce HbA1c levels than metformin, Merck & Co.’s Januvia (sitagliptin), read more »

FDA Approves Bydureon once-weekly treatment for Type 2 diabetes

Tuesday, June 19th, 2012 | 0 Comments
Recently approved T2 treatment Bydureon is becoming available in pharmacies in the USA nationwide this month. The approval was in part based on clinical experience with Byetta (exenatide) injection, a twice-daily form of exenatide that has been available in the U.S. since read more »